Shares of DocuSign Inc. rose approximately 4.3% on Friday, closing at $47.96, as investors refocused on the company’s push into artificial intelligence-powered contract management just one day after the close of its fiscal first quarter. The uptick pushed DocuSign’s market capitalization to nearly $10 billion.
The IAM Platform Takes Center Stage
All eyes are now on DocuSign’s upcoming earnings report, which will reveal whether its Intelligent Agreement Management (IAM) platform is gaining real traction beyond the narrative stage. IAM is designed to handle the entire contract lifecycle—from storage and review to automation—rather than simply facilitating electronic signatures. The platform has been a key part of CEO Allan Thygesen’s strategy to transform DocuSign into an “agreement system of action.”
Revenue Guidance and Key Metrics
For the quarter ended April 30, DocuSign expects revenue in the range of $822 million to $826 million. For fiscal 2027, the company has set revenue guidance between $3.484 billion and $3.496 billion, with annual recurring revenue (ARR)—its primary subscription metric—expected to grow by 8.25% to 8.75%. In the previous quarter (Q4), revenue rose 8% to $836.9 million, with subscription revenue reaching $819 million. Billings crossed the $1 billion mark for the first time, a milestone that CFO Blake Grayson has indicated will be the last time the company highlights billings as its headline metric, shifting focus to ARR going forward.
Buyback and Customer Metrics
DocuSign’s board authorized an additional $2 billion share buyback program, bringing the total available repurchase capacity to $2.6 billion as of March 17. The program has no minimum purchase requirement or expiration date. The company’s annual report shows over 1.8 million customers and more than 1 billion global users. As of January 31, DocuSign had over 25,000 IAM customers, and Thygesen noted that IAM customers have generated over $350 million in ARR in roughly 18 months.
Competitive Risks and Analyst Caution
Despite the optimism, DocuSign faces significant competitive threats. The company has identified Adobe Acrobat Sign as its primary competitor in the global e-signature market. Advances in large language models, generative AI, and general-purpose agents could lower the cost of contract analysis and make it easier for rivals to replicate DocuSign’s capabilities. Larger competitors may also leverage their resources to bundle competing offerings at lower prices, putting pressure on DocuSign’s margins.
Wall Street remains cautious. According to MarketBeat, of 19 brokerages covering DocuSign, only three rate it a buy, 14 recommend hold, and two advise sell. Following the March results, Robert W. Baird, Wells Fargo, Morgan Stanley, and Royal Bank of Canada all lowered their price targets. Friday’s stock move appears more like a tentative test than a decisive turnaround.
DocuSign still has strong fundamentals: a profitable subscription business, a substantial buyback program, and a growing AI product. What investors lack is proof that IAM can drive sustained growth without making pricing more difficult as competition from Adobe and emerging AI tools intensifies.
